SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Akorn, Inc.

NEW YORK--()--Levi & Korsinsky announces it has commenced an investigation of Akorn, Inc. (NASDAQ:AKRX) concerning possible violations of federal securities laws.

On February 26, 2018, Fresenius SE & Co. KGaA—which had been expected to close on an acquisition of Akorn—announced that it is conducting an investigation into alleged breaches of U.S. Food and Drug Administration “data integrity requirements relating to product development at Akorn.” Following this news, shares of Akorn were down more than 33% on intraday trading on February 27, 2018. To obtain additional information, go to:

http://www.zlkdocs.com/AKRX-Info-Request-Form-6495

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
Tel: 212-363-7500
Toll Free: 877-363-5972
Fax: 212-363-7171
www.zlk.com

Release Summary

Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Akorn, Inc.

Contacts

Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
Tel: 212-363-7500
Toll Free: 877-363-5972
Fax: 212-363-7171
www.zlk.com